AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) Short Interest Update

AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) saw a significant decline in short interest in January. As of January 31st, there was short interest totalling 8,300 shares, a decline of 90.5% from the January 15th total of 87,400 shares. Based on an average trading volume of 2,612,200 shares, the short-interest ratio is currently 0.0 days.

AXIM Biotechnologies Price Performance

Shares of AXIM traded down $0.00 during trading hours on Wednesday, reaching $0.00. 82,420 shares of the stock traded hands, compared to its average volume of 810,690. AXIM Biotechnologies has a 52 week low of $0.00 and a 52 week high of $0.02.

About AXIM Biotechnologies

AXIM Biotechnologies, Inc engages in the development and sale of diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and other diseases. The company is developing tests for dye eye diseases; SARS-CoV-2 neutralizing antibody tests; and fentanyl neutralizing antibody tests. It also developing a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring.